SG
Sampoorna Ganta
About Sampoorna Ganta
Data last updated:
Sampoorna Ganta has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Bell Pharmaceuticals And Cosmetics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Bell Pharmaceuticals And Cosmetics Private Limited at ₹7.09 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bell Pharmaceuticals And Cosmetics Private Limited U24290TG2021PTC155399 | Director | 29 Sep 2021 | 2021 | ₹7.09 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sampoorna Ganta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sampoorna Ganta
Sampoorna Ganta has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Bell Pharmaceuticals And Cosmetics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Bell Pharmaceuticals And Cosmetics Private Limited at ₹7.09 Cr (FY 2025).
Sampoorna Ganta is associated with 1 company as Director, including Bell Pharmaceuticals And Cosmetics Private Limited (₹7.09 Cr).
Sampoorna Ganta has expertise in General Business.
Sampoorna Ganta has 5 years in corporate governance.
By reported revenue, the largest current company of Sampoorna Ganta is Bell Pharmaceuticals And Cosmetics Private Limited, with revenue of ₹7.09 Cr (FY 2025).
Sampoorna Ganta currently holds positions at 1 company: Bell Pharmaceuticals And Cosmetics Private Limited (₹7.09 Cr).